Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis

We analyzed 50 patients who achieved at least a very good partial response in the RV-MM-EMN-441 study. Patients received consolidation with autologous stem-cell transplantation (ASCT) or cyclophosphamide-lenalidomide-dexamethasone (CRD), followed by Lenalidomide-based maintenance. We assessed minima...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Oliva, Stefania, Gambella, Manuela, Gilestro, Milena, Muccio, Vittorio Emanuele, Gay, Francesca, Drandi, Daniela, Ferrero, Simone, Passera, Roberto, Pautasso, Chiara, Bernardini, Annalisa, Genuardi, Mariella, Patriarca, Francesca, Saraci, Elona, Petrucci, Maria Teresa, Pescosta, Norbert, Liberati, Anna Marina, Caravita, Tommaso, Conticello, Concetta, Rocci, Alberto, Musto, Pellegrino, Boccadoro, Mario, Palumbo, Antonio, Omedè, Paola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351601/
https://ncbi.nlm.nih.gov/pubmed/27779105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12641
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia